U3S Chemsolutions Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.50 M
as on 16-11-2024
- Company Age 11 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 Cr
as on 16-11-2024
- Satisfied Charges ₹ 2.75 Cr
as on 16-11-2024
- Revenue 25.80%
(FY 2023)
- Profit 61.12%
(FY 2023)
- Ebitda 62.91%
(FY 2023)
- Net Worth 39.01%
(FY 2023)
- Total Assets 41.14%
(FY 2023)
About U3S Chemsolutions
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹4.00 Cr. The company has closed loans amounting to ₹2.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashish Sawant, Daljeetsingh Shan, and Gurunath Mhaskar serve as directors at the Company.
- CIN/LLPIN
U74120MH2013PTC249127
- Company No.
249127
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Oct 2013
- Date of AGM
18 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at U3S Chemsolutions?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Sawant  | Director | 23-Aug-2017 | Current |
| Daljeetsingh Shan | Director | 14-Nov-2018 | Current |
| Gurunath Mhaskar | Additional Director | 17-Apr-2024 | Current |
Financial Performance of U3S Chemsolutions.
U3S Chemsolutions Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.8% increase. The company also saw a substantial improvement in profitability, with a 61.12% increase in profit. The company's net worth Soared by an impressive increase of 39.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of U3S Chemsolutions?
In 2023, U3S Chemsolutions had a promoter holding of 95.70% and a public holding of 4.30%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
₹40.00 M
₹27.50 M
Charges Breakdown by Lending Institutions
- Others : 4.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Feb 2023 | Others | ₹4.00 Cr | Open |
| 14 May 2018 | Others | ₹2.75 Cr | Satisfied |
How Many Employees Work at U3S Chemsolutions?
Unlock and access historical data on people associated with U3S Chemsolutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of U3S Chemsolutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped U3S Chemsolutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
